David Maussang

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

Pieter J. Gaillard, Chantal C.M. Appeldoorn, Rick Dorland et al. · PLoS ONE · 2014 · 280 citations · Full text

Nanotherapeutics, Brain Tumor Growth, Pharmacotherapy +16

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

Sven Jähnichen, Christophe Blanchetot, David Maussang et al. · Proceedings of the National Academy of Sciences · 2010 · 244 citations · Full text

Cell Therapy, Engineering, Immunology +21

Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis

David Maussang, Dennis Verzijl, Marijke van Walsum et al. · Proceedings of the National Academy of Sciences · 2006 · 232 citations · Full text

Inactive Mutant, Medicine, Immunology +10

HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6–STAT3 Axis

Erik Slinger, David Maussang, Andreas Schreiber et al. · Science Signaling · 2010 · 226 citations

Toll-Like Receptor Signaling in Small Intestinal Epithelium Promotes B-Cell Recruitment and IgA Production in Lamina Propria

Limin Shang, Masayuki Fukata, Nanthakumar Thirunarayanan et al. · Gastroenterology · 2008 · 196 citations · Full text

Inflammation, Toll-like Receptors, Mucosal Immunology +13